What it is / mechanism 5-Amino-1MQ is a selective, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide (consuming the methyl donor SAM) to form 1-methylnicotinamide, diverting nicotinamide away from the NAD+ salvage pathway
Related Topics Tirzepatide Deep Dive mechanism, clinical results, and comparison context Retatrutide vs Tirzepatide triple versus dual receptor comparison Semaglutide vs Tirzepatide direct comparison and evidence boundaries GLP-1 Dosing Optimizer split-frequency modeling and plasma curves Full Reconstitution Calculator all-peptide vial math and custom BAC volumes GLP-1 Lean Mass Guide protein, training, and body-composition evidence References Tirzepatide for non-diabetic obesity SURMOUNT-1, 72 weeks, 5/10/15 mg, weight -15.0/-19.5/-20.9% (treatment-regimen estimand), DXA and pulse in Table S7: Jastreboff NEJM 2022
Discuss health history, current medication, and fertility goals
Risks, Unknowns, and Individual Variability Long-term safety data for DSIP are lacking, and its chronic effects on sleep architecture, neuroendocrine function, or cognitive health remain unknown
